Vialwirebiotech, curated
October 3, 2026, 3:49 AM
May 18, 2026
- 3:49 AM · Pharmaceutical Technology3:49 AMFDA approves Enhertu for two HER2-positive early breast cancer indications — Pharmaceutical Technology
May 17, 2026
- 8:00 PM · Nature Biotechnology8:00 PMIntellia heads to FDA with first in vivo CRISPR-based gene editing therapy — Nature Biotechnology
- 7:00 AM · Ars Technica — Science7:00 AMA revolutionary cancer treatment could transform autoimmune disease — Ars Technica — Science